SWOG clinical trial number
SWOG-7434
Evaluation of 5-Fluorouracil Infusion with Mitomycin C vs 5-Fluorouracil Infusion with Methyl CCNU in the Treatment of Gastrointestinal Malignancies
Closed
Abbreviated Title
Evaluation of 5-Fluorouracil Infusion with Mitomycin C vs 5-Fluorouracil Infusion with Methyl CCNU in the Treatment of Gastrointestinal Malignancies
Activated
03/14/1975
Closed
10/01/1976
Publication Information Expand/Collapse
1983
Southwest Oncology Group experience with 5-fluorouracil in carcinoma of the colon.
1979
5-FU infusion with Mitomycin-C vs. 5-FU infusion with Methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest Oncology Group study.
The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treatment with chemo- therapy. A Southwest Oncology Group study.
1978
5-FU infusion with mitomycin-C versus 5-FU infusion with methyl-CCNU in the treatment of advanced colon cancer.
1977
5-FU infusion with mitomycin-C vs. 5-FU infusion with methyl CCNU in the treatment of advanced colon cancer.